Cargando…
Case Report: Integrated echocardiographic assessment guided Liwen procedure for treating obstructive hypertrophic cardiomyopathy with ventricular aneurysm
Hypertrophic cardiomyopathy (HCM) is a genetic myocardial disease, with an estimated incidence of 0.2%–6%, and is the main cause of sudden cardiac death (SCD) in young athletes. Left ventricular apical aneurysm (LVAA) is a rare subtype of HCM, accounting for about 5% of HCM patients, and has a highe...
Autores principales: | Zhang, Rui, Zhao, Fan, Wang, Jing, Qin, Yahong, Wang, Tingting, Chu, Ai-Ai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646534/ https://www.ncbi.nlm.nih.gov/pubmed/38028451 http://dx.doi.org/10.3389/fcvm.2023.1278457 |
Ejemplares similares
-
First-in-man application of Liwen RF™ ablation system in the treatment of drug-resistant hypertrophic obstructive cardiomyopathy
por: Wang, Zihao, et al.
Publicado: (2022) -
Trans-Septal Myocardial Biopsy in Hypertrophic Cardiomyopathy Using the Liwen Procedure: An Introduction of a Novel Technique
por: Han, Chao, et al.
Publicado: (2021) -
Mid-Ventricular Hypertrophic Obstructive Cardiomyopathy Complicated by an Apical Aneurysm, Presenting as Ventricular Tachycardia
por: Petrou, Emmanouil, et al.
Publicado: (2014) -
Electrocardiographic and Echocardiographic Predictors of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
por: Mandeş, Leonard, et al.
Publicado: (2022) -
Clinical Efficacy and Safety of Cox-Maze IV Procedure for Atrial Fibrillation in Patients With Hypertrophic Obstructive Cardiomyopathy
por: Meng, Yanhai, et al.
Publicado: (2021)